FPH vs REGN · P/E 8.4, rev $237.9M vs P/E 14, rev $14.34B
Five Point Holdings LLC (FPH) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Five Point Holdings LLC (FPH) is a real estate - development company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FPH revenue for 2024-12-31 was $237.9M. Net income was $177.6M. Revenue was up 12.4% from 2023-12-31 to 2024-12-31. FPH currently screens at market cap $759.0M and trailing P/E 8.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FPH currently screens at market cap $759.0M and trailing P/E 8.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FPH and REGN stock pages for the full models.
Not investment advice.